LENZ Therapeutics, Inc. short interest in 2026
In 2026, LENZ Therapeutics, Inc.'s disclosed short interest ran from 27.89% of shares outstanding on 15 Jan 2026 to 33.83% on 15 Sep 2026, a change of +5.94 percentage points. The year's high was 37.83% on 15 Jul 2026 and its low 23.21% on 30 Jan 2026, averaging 31.93% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.31 days on 15 Jun 2026. Full history: LENZ Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 27.89% (15 Jan 2026)
- End of year
- 33.83% (15 Sep 2026)
- Change
- +5.94 pp
- High
- 37.83% (15 Jul 2026)
- Low
- 23.21% (30 Jan 2026)
- Average
- 31.93%
- Highest days to cover
- 20.31 (15 Jun 2026)
- SEC filings marked
- 7
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 27.89% | 7.68 | results (8-K) |
| 30 Jan 2026 | 23.21% | 5.51 | |
| 13 Feb 2026 | 26.95% | 9.39 | |
| 27 Feb 2026 | 28.45% | 12.85 | |
| 13 Mar 2026 | 30.72% | 14.08 | |
| 31 Mar 2026 | 28.81% | 5.87 | 10-K filed, results (8-K) |
| 15 Apr 2026 | 30.23% | 13.90 | |
| 30 Apr 2026 | 34.20% | 14.22 | |
| 15 May 2026 | 35.39% | 11.02 | 10-Q filed, results (8-K) |
| 29 May 2026 | 32.63% | 12.63 | |
| 15 Jun 2026 | 33.10% | 20.31 | |
| 30 Jun 2026 | 33.27% | 11.03 | |
| 15 Jul 2026 | 37.83% | 10.46 | |
| 31 Jul 2026 | 36.10% | 11.82 | |
| 14 Aug 2026 | 35.63% | 12.53 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 34.61% | 18.89 | |
| 15 Sep 2026 | 33.83% | 14.55 |
See also: LENZ Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.